Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.3 USD | -0.30% | +1.60% | +7.95% |
10:48pm | Cigna to offer Humira rivals with $0 copay at specialty pharmacy | RE |
05:07pm | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
Official Publications
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Official Publications